Relev-X Capsule (Glucosamine-free)
Natural health product licensed in Canada
- Licence holder
- Platinum Naturals Ltd.
- NPN or DIN-HM
- 80102804
- Status
- Active licence
- Licence date
- 16 July 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Harpagophytum procumbens Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 300 mg | 50 mg | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 8 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 260 mg | 65 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 50 % Docosahexaenoic acid | 250 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 50 % Docosahexaenoic acid | 250 mg | Not calculated |
| Curcuma longa Source : Racine Potency : 95 % Curcuminoids | 100 mg | Not calculated |
| Boswellia serrata Source : Stem bark resin Extraction ratio : 6:1 Dry plant equivalent : 180 mg Potency : 70 % Boswellic acids | 30 mg | Not calculated |
Non-medicinal ingredients
Chlorophylle, Cire d'Abeille, blanche, Hypromellose, Triglycérides à chaîne moyenne, Lécithine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Source of omega-3 fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80102804
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.